0.5359
price up icon12.84%   0.061
pre-market  시장 영업 전:  .53   -0.0059   -1.10%
loading
전일 마감가:
$0.4749
열려 있는:
$0.526
하루 거래량:
649.23K
Relative Volume:
0.29
시가총액:
$75.87M
수익:
-
순이익/손실:
$-119.76M
주가수익비율:
-0.397
EPS:
-1.35
순현금흐름:
$-55.17M
1주 성능:
+22.44%
1개월 성능:
+78.63%
6개월 성능:
-12.10%
1년 성능:
-89.98%
1일 변동 폭
Value
$0.5219
$0.5359
1주일 범위
Value
$0.4385
$0.5359
52주 변동 폭
Value
$0.295
$10.62

Applied Therapeutics Inc Stock (APLT) Company Profile

Name
명칭
Applied Therapeutics Inc
Name
전화
212-220-9226
Name
주소
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Name
직원
36
Name
트위터
@Applied_Tx
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
APLT's Discussions on Twitter

APLT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
APLT
Applied Therapeutics Inc
0.5359 67.23M 0 -119.76M -55.17M -1.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-23 다운그레이드 William Blair Outperform → Mkt Perform
2024-12-02 다운그레이드 UBS Buy → Neutral
2024-11-29 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2024-07-31 개시 William Blair Outperform
2024-03-26 개시 RBC Capital Mkts Outperform
2024-02-22 개시 Leerink Partners Outperform
2022-01-04 다운그레이드 Barclays Overweight → Equal Weight
2021-08-27 다운그레이드 Goldman Neutral → Sell
2021-06-25 재개 Goldman Neutral
2020-10-08 개시 Truist Buy
2020-04-22 개시 Goldman Buy
2020-02-27 개시 Barclays Overweight
2019-06-10 개시 Citigroup Buy
2019-06-10 개시 Cowen Outperform
2019-06-10 개시 Robert W. Baird Outperform
모두보기

Applied Therapeutics Inc 주식(APLT)의 최신 뉴스

pulisher
12:18 PM

What drives Applied Therapeutics Inc. stock priceExceptional financial outcomes - Autocar Professional

12:18 PM
pulisher
Jul 23, 2025

Applied Therapeutics Inc. Stock Analysis and ForecastSkyrocketing investment returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Applied Therapeutics Inc. stockPhenomenal returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

How Applied Therapeutics Inc. stock reacts to Fed policy changesTop Analyst Picks - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics LawsuitAPLT - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 20, 2025

Is Applied Therapeutics Inc. a good long term investmentExplosive earnings growth - printweek.in

Jul 20, 2025
pulisher
Jul 18, 2025

Applied Therapeutics, Inc. shares rise 1.28% premarket after Intesa Sanpaolo invests in NUCLIDIUM's cancer radiotheranostics. - AInvest

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Applied Therapeutics Inc. stock price move sharplyReal Time Stock Signal - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Applied Therapeutics Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Applied Therapeutics Inc. stock attracts strong analyst attentionFree Investing Community - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Why Did Rapport Therapeutics Plunge 15.68%? Regulatory Setbacks, Financial Strain - AInvest

Jul 14, 2025
pulisher
Jul 08, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. LawsuitAPLT - ACCESS Newswire

Jul 08, 2025
pulisher
Jul 06, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit – APLT - ACCESS Newswire

Jul 06, 2025
pulisher
Jul 03, 2025

Applied Therapeutics Requests to Dismiss Class Action Filed by Investors - TradingView

Jul 03, 2025
pulisher
Jul 03, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Connect - ACCESS Newswire

Jul 03, 2025
pulisher
Jun 29, 2025

Applied Therapeutics Plummets 15% Amid Technical Mystery: What's Behind the Drop? - AInvest

Jun 29, 2025
pulisher
Jun 24, 2025

Pre-market Movers: NKTR, INM, IBIO, IBO... - RTTNews

Jun 24, 2025
pulisher
Jun 23, 2025

Applied Therapeutics Plummets 12.5%: What’s Behind the Unexplained Sell-Off? - AInvest

Jun 23, 2025
pulisher
Jun 17, 2025

Applied Therapeutics promotes two executives to leadership roles By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Announces New Chief Medical Officer - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

APLT Announces Key Executive Promotions | APLT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Promotes Evan Bailey to Chief Medical Officer - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Announces Key Leadership Appointments | APLT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics promotes two executives to leadership roles - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Announces Key Leadership Appointments - GlobeNewswire

Jun 17, 2025
pulisher
Jun 13, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New Investment in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

California State Teachers Retirement System Purchases 64,316 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Applied Therapeutics holds annual stockholders meeting By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Applied Therapeutics Elects New Director at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Applied Therapeutics holds annual stockholders meeting - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Buys New Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Analysts Set Applied Therapeutics, Inc. (NASDAQ:APLT) Target Price at $6.10 - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) Target Price at $6.10 - MarketBeat

Jun 10, 2025
pulisher
Jun 09, 2025

Wellington Management Group LLP Boosts Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 09, 2025

Applied Therapeutics Inc (APLT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Applied Therapeutics Inc 주식 (APLT) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Funtleyder Leslie D.
See Remarks
Mar 04 '25
Sale
0.44
14,502
6,381
390,459
Chinoporos Constantine
See Remarks
Mar 04 '25
Sale
0.44
447
197
271,436
Funtleyder Leslie D.
See Remarks
Feb 06 '25
Sale
0.61
22,950
14,000
404,961
Perfetti Riccardo
Chief Medical Officer
Feb 06 '25
Sale
0.61
86,078
52,508
900,775
Chinoporos Constantine
See Remarks
Feb 06 '25
Sale
0.61
28,117
17,151
271,883
Funtleyder Leslie D.
Chief Financial Officer
Aug 22 '24
Sale
5.83
13,530
78,880
277,911
Perfetti Riccardo
Chief Medical Officer
Aug 22 '24
Sale
5.83
22,681
132,230
986,853
Shendelman Shoshana
President and CEO
Aug 13 '24
Sale
6.18
357,423
2,208,874
4,810,430
Shendelman Shoshana
President and CEO
Aug 12 '24
Sale
5.98
300,000
1,794,000
5,167,853
Shendelman Shoshana
President and CEO
Aug 14 '24
Sale
5.93
119,591
709,175
4,690,839
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
자본화:     |  볼륨(24시간):